A Study to Learn About the Study Medicine (Called Ritlecitinib) for the Potential Treatment of Severe Alopecia Areata in Children 6 to Less Than 12 Years of Age

An Interventional PK, PD, Phase 1, Open-Label Study to Investigate PK and PD of Multiple-Dose Ritlecitinib in Children 6 to Less
Than 12 Years of Age With Severe Alopecia Areata

Category & Conditions: Immune System Diseases and Conditions

Medicine: ritlecitinib (PF-06651600)

ClinicalTrials.gov Identifier (NCT): NCT05650333

Protocol ID: B7981031

Print Download

Open Plain Language Summary Result: Click here